Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma

doi:10.3748/wjg.v19.i24.3872

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 24

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7849)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

598

HTML

4869

Figures (1-5)

129

Tables (1-3)

154

Sum=5750

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1027

Download

1072

Sum=2099

Jun 28, 2013 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (115)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Jun 28, 2013; 19(24): 3872-3882
Published online Jun 28, 2013. doi: 10.3748/wjg.v19.i24.3872

Full Size Figure Download Figure

Figure 2 Comparison of combination of radiofrequency ablation and transcatheter arterial chemoembolization with radiofrequency ablation alone for hepatocellular carcinoma in terms of overall survival rates (A-D) and recurrence-free survival rates (E-G). A, E: Meta-analysis of 1-year results; B: Meta-analysis of 2-year results; C, F: Meta-analysis of 3-year results; D, G: Meta-analysis of 5-year results. RFA: Radiofrequency ablation; TACE: Transcatheter arterial chemoembolization; OR: Odds ratio.

Citation: Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2013; 19(24): 3872-3882
URL: https://www.wjgnet.com/1007-9327/full/v19/i24/3872.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i24.3872